CD4+Foxp3+Helios+ Treg cells co-expressed the suppressive molecules PD-1, CTLA-4, and CD39, suggesting that the phenotype of these Treg cells in the tumor of CRC patients is highly suppressive (Figure 2C) [90]. This evidence concerns the gene PDCD1 and neoplasm.